Steven Daniel joins Cofactor Genomics as Vice President of Business Development — Leading Cofactor’s commercial efforts to grow the Predictive Immune Modeling market   — San [...]

Cofactor Joins FNIH Biomarkers Consortium to Add Predictive Immune Modeling Expertise as New Resource for Multidimensional Biomarker Discovery — Contributing to both the Cancer and [...]

SAN FRANCISCO, Apr. 4, 2019 (FORBESBOOKS RADIO) -Dave Messina is COO of Cofactor Genomics; their multidimensional biomarker tools use RNA to enable doctors, drug developers and researchers to [...]

SAN FRANCISCO, Apr. 2, 2019 (CLINICAL OMICS) – Jarret Glasscock is the founder and CEO of Cofactor Genomics, a diagnostics company leveraging the power of RNA and Predictive Immune Modeling [...]

SAN FRANCISCO, Apr. 2, 2019 (CLINICAL OMICS) – In 2013, much of the world was introduced to the burgeoning field of precision medicine when world-famous actress, Angelina Jolie, announced [...]

Cofactor Genomics to Present on Predictive Immune Modeling at 2019 American Association for Cancer Research Annual Meeting — Presenting early data in collaboration with TriStar Technology [...]

Awards Scientists and Clinicians Who Create Predictive Immune Models and Multidimensional Biomarkers Using the Cofactor ImmunoPrismTM Assay NEW YORK (BusinessWire), February 6, 2019 [...]

SAN FRANCISCO, Feb. 4, 2019 (FIERCE PHARMA) – Advances in new immunotherapies and novel combinations of therapies have resulted in an explosion of oncology clinical trials. While many of [...]

SAN FRANCISCO, Jan. 30, 2019 (STAT NEWS) – When your oncology drug is finally ready to move into clinical trials, it feels like you’ve made it to the Super Bowl. These are the big leagues; [...]

SAN FRANCISCO, Dec. 21, 2018 (TRAPELO) – In oncology today, diagnostic technology tools are key to helping scientists unlock the potential of precision medicine, so we were thrilled [...]